首页 | 本学科首页   官方微博 | 高级检索  
检索        

紫草素对卵巢癌细胞SKOV3/DDP顺铂耐药的逆转作用
引用本文:许静,郭哲,王秋宇,梁殿迅.紫草素对卵巢癌细胞SKOV3/DDP顺铂耐药的逆转作用[J].中国病理生理杂志,2018,34(9):1616-1621.
作者姓名:许静  郭哲  王秋宇  梁殿迅
作者单位:南阳市中心医院妇产科, 河南 南阳 473000
摘    要:目的:探讨紫草素是否逆转卵巢癌细胞SKOV3/DDP的顺铂耐药效应及其作用机制。方法:采用CCK-8法确定紫草素和顺铂的最佳作用条件,流式细胞术检测细胞的周期分布及凋亡率;Western blot检测周期及凋亡相关调控因子细胞周期蛋白D1(cyclin D1)、周期蛋白依赖性激酶2(CDK2)、P18、p-Rb、Bcl-2、Bax和cleaved caspase-3的蛋白水平。结果:CCK-8实验结果显示,相较于单用顺铂,联合使用紫草素对顺铂耐药卵巢癌细胞SKOV3/DDP的生长抑制作用较为显著。此外,联用紫草素和顺铂可显著抑制细胞周期G_1/S转化,并增加细胞早期凋亡率。Western blot结果显示,相较于顺铂处理组,紫草素和顺铂联用组的cyclin D1、CDK2、p-Rb及Bcl-2的蛋白水平显著降低,而P18、Bax及cleaved caspase-3的蛋白表达显著增加。结论:紫草素可逆转卵巢癌SKOV3/DDP细胞的顺铂耐药效应,其作用机制可能与影响细胞周期及凋亡相关因子的表达,进而抑制细胞活力促进细胞凋亡相关。

关 键 词:紫草素  卵巢癌  顺铂  细胞凋亡  细胞周期  
收稿时间:2017-10-11

Reversal effect of shikonin on cisplatin resistance of ovarian cancer SKOV3/DDP cells
XU Jing,GUO Zhe,WANG Qiu-yu,LIANG Dian-xun.Reversal effect of shikonin on cisplatin resistance of ovarian cancer SKOV3/DDP cells[J].Chinese Journal of Pathophysiology,2018,34(9):1616-1621.
Authors:XU Jing  GUO Zhe  WANG Qiu-yu  LIANG Dian-xun
Institution:Department of Obstetrics and Gynecology, Nanyang Center Hospital, Nanyang 473000, China
Abstract:AIM:To explore the reversal effect of shikonin on cisplatin resistance of ovarian cancer SKOV3/DDP cells and its potential mechanism. METHODS:The proper conditions of treatment with shikonin and cisplatin were determined by CCK-8 assay. The cell cycle and apoptotic rate were analyzed by flow cytometry. The protein levels of cell cycle-and apoptotic-related molecules, such as cyclin D1, cyclin-dependent kinases 2 (CDK2), P18, p-Rb, Bcl-2, Bax and cleaved caspase-3, were determined by Western blot. RESULTS:The results of CCK-8 assay showed that compared with cisplatin group, combined treatment with shikonin and cisplatin had a better inhibitory effect on the growth of cisplatin-resistant SKOV3/DDP cells. The cell cycle G1/S transition was inhibited, while early apoptotic rate was increased after combined use of shikonin and cisplatin. The results of Western blot showed that compared with cisplatin group, the cells in combination group had lower protein levels of cyclin D1, CDK2, p-Rb and Bcl-2, accompanied with higher protein levels of P18, Bax and cleaved caspase-3. CONCLUSION:Shikonin reverses the cisplatin resistance of ovarian cancer SKOV3/DDP cells. The mechanism may be related to the regulation of cell cycle-and apoptotic-related molecules, and further inhibition of cell viability and promotion of cell apoptosis.
Keywords:Shikonin  Ovarian cancer  Cisplatin  Apoptosis  Cell cycle
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号